The National Institute on Aging is offering grants for Phase I to III clinical trials aimed at preventing, delaying, or treating Alzheimer’s disease and age-related dementias. This grant utilizes the Alzheimer’s Clinical Trials Consortium (ACTC) trial coordination and management infrastructure. Closing date for applications is November 24, 2020.
Opportunity ID: 299502
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-513 |
| Funding Opportunity Title: | Alzheimer’s Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.866 — Aging Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Dec 18, 2017 |
| Last Updated Date: | Nov 24, 2020 |
| Original Closing Date for Applications: | Jan 07, 2021 |
| Current Closing Date for Applications: | Nov 24, 2020 |
| Archive Date: | Dec 24, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments State governments Public housing authorities/Indian housing authorities For profit organizations other than small businesses Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal governments (Federally recognized) Special district governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
This Funding Opportunity Announcement (FOA) invites applications to develop and implement Phase I to III clinical trials of promising pharmacological and non-pharmacological interventions that may prevent, delay, or treat the symptoms of Alzheimer’s disease (AD) and other age-related dementias using the Alzheimer’s disease Clinical Trials Consortium (ACTC) trial coordination and management infrastructure. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-513.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Expired and Re-issued as PAR-20-309 | Nov 24, 2020 | |
| Dec 18, 2017 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-513 |
| Funding Opportunity Title: | Alzheimer’s Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.866 — Aging Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Dec 18, 2017 |
| Last Updated Date: | Nov 24, 2020 |
| Original Closing Date for Applications: | Jan 07, 2021 |
| Current Closing Date for Applications: | Nov 24, 2020 |
| Archive Date: | Dec 24, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments State governments Public housing authorities/Indian housing authorities For profit organizations other than small businesses Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal governments (Federally recognized) Special district governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
This Funding Opportunity Announcement (FOA) invites applications to develop and implement Phase I to III clinical trials of promising pharmacological and non-pharmacological interventions that may prevent, delay, or treat the symptoms of Alzheimer’s disease (AD) and other age-related dementias using the Alzheimer’s disease Clinical Trials Consortium (ACTC) trial coordination and management infrastructure. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-513.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-513 |
| Funding Opportunity Title: | Alzheimer’s Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.866 — Aging Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 18, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 07, 2021 |
| Archive Date: | Feb 12, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments City or township governments Private institutions of higher education Small businesses Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education For profit organizations other than small businesses Public housing authorities/Indian housing authorities State governments Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) invites applications to develop and implement Phase I to III clinical trials of promising pharmacological and non-pharmacological interventions that may prevent, delay, or treat the symptoms of Alzheimer’s disease (AD) and other age-related dementias using the Alzheimer’s disease Clinical Trials Consortium (ACTC) trial coordination and management infrastructure. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-513.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00237131 | Feb 27, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259128 | Feb 27, 2018 | Nov 25, 2020 | View |
Package 1
Mandatory forms
299502 RR_SF424_2_0-2.0.pdf
299502 PHS398_CoverPageSupplement_4_0-4.0.pdf
299502 RR_OtherProjectInfo_1_4-1.4.pdf
299502 PerformanceSite_2_0-2.0.pdf
299502 RR_KeyPersonExpanded_2_0-2.0.pdf
299502 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
299502 RR_Budget_1_4-1.4.pdf
299502 RR_SubawardBudget30_1_4-1.4.pdf
299502 PHS398_ModularBudget_1_2-1.2.pdf
299502 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
299502 RR_SF424_2_0-2.0.pdf
299502 PHS398_CoverPageSupplement_5_0-5.0.pdf
299502 RR_OtherProjectInfo_1_4-1.4.pdf
299502 PerformanceSite_2_0-2.0.pdf
299502 RR_KeyPersonExpanded_2_0-2.0.pdf
299502 PHS398_ResearchPlan_4_0-4.0.pdf
299502 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
299502 RR_Budget_1_4-1.4.pdf
299502 RR_SubawardBudget30_1_4-1.4.pdf
299502 PHS398_ModularBudget_1_2-1.2.pdf
299502 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
